AHR and obesity due to melanocortin 4 receptor deficiency: In conclusion, these data suggested that the repression of classical AhR signaling, a phenotype driven by exposure to BMAs, is predictive of worse clinical outcomes in MM patients, supporting the evidence that MM patients with obesity have increased risk for disease progression.